Global Acquired Immunodeficiency Syndrome Market Research Report 2023
Acquired immunodeficiency syndrome (AIDS) is one of the most widespread, catastrophic, and incurable diseases among humans in the world. According to a report published by the World Health Organization (WHO) in 2013, deaths caused by HIV ranked sixth in the total number of deaths in the world. Human immunodeficiency virus (HIV) presents itself as a complex mixture of symptoms, all related to severe immune compromise, while AIDS is an advanced stage of HIV infection.
According to QYResearch’s new survey, global Acquired Immunodeficiency Syndrome market is projected to reach US$ 1962.2 million in 2029, increasing from US$ 1536 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Acquired Immunodeficiency Syndrome market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Acquired Immunodeficiency Syndrome market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Acquired Immunodeficiency Syndrome market is projected to reach US$ 1962.2 million in 2029, increasing from US$ 1536 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Acquired Immunodeficiency Syndrome market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Acquired Immunodeficiency Syndrome market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Takeda
- AstraZeneca Eli Lilly and Company
- Merck KGaA
- Sanofi
- Pfizer
- Amgen
- Biogen
- Novartis
- Actelion
- Daiichi Sankyo Company
- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
- Hospital Pharmacy
- Retail Pharmacy
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acquired Immunodeficiency Syndrome Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
1.2.3 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.3 Market by Application
1.3.1 Global Acquired Immunodeficiency Syndrome Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Acquired Immunodeficiency Syndrome Market Perspective (2018-2029)
2.2 Acquired Immunodeficiency Syndrome Growth Trends by Region
2.2.1 Global Acquired Immunodeficiency Syndrome Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Acquired Immunodeficiency Syndrome Historic Market Size by Region (2018-2023)
2.2.3 Acquired Immunodeficiency Syndrome Forecasted Market Size by Region (2024-2029)
2.3 Acquired Immunodeficiency Syndrome Market Dynamics
2.3.1 Acquired Immunodeficiency Syndrome Industry Trends
2.3.2 Acquired Immunodeficiency Syndrome Market Drivers
2.3.3 Acquired Immunodeficiency Syndrome Market Challenges
2.3.4 Acquired Immunodeficiency Syndrome Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Acquired Immunodeficiency Syndrome Players by Revenue
3.1.1 Global Top Acquired Immunodeficiency Syndrome Players by Revenue (2018-2023)
3.1.2 Global Acquired Immunodeficiency Syndrome Revenue Market Share by Players (2018-2023)
3.2 Global Acquired Immunodeficiency Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acquired Immunodeficiency Syndrome Revenue
3.4 Global Acquired Immunodeficiency Syndrome Market Concentration Ratio
3.4.1 Global Acquired Immunodeficiency Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acquired Immunodeficiency Syndrome Revenue in 2022
3.5 Acquired Immunodeficiency Syndrome Key Players Head office and Area Served
3.6 Key Players Acquired Immunodeficiency Syndrome Product Solution and Service
3.7 Date of Enter into Acquired Immunodeficiency Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ACQUIRED IMMUNODEFICIENCY SYNDROME BREAKDOWN DATA BY TYPE
4.1 Global Acquired Immunodeficiency Syndrome Historic Market Size by Type (2018-2023)
4.2 Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Type (2024-2029)
5 ACQUIRED IMMUNODEFICIENCY SYNDROME BREAKDOWN DATA BY APPLICATION
5.1 Global Acquired Immunodeficiency Syndrome Historic Market Size by Application (2018-2023)
5.2 Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Acquired Immunodeficiency Syndrome Market Size (2018-2029)
6.2 North America Acquired Immunodeficiency Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Acquired Immunodeficiency Syndrome Market Size by Country (2018-2023)
6.4 North America Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Acquired Immunodeficiency Syndrome Market Size (2018-2029)
7.2 Europe Acquired Immunodeficiency Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Acquired Immunodeficiency Syndrome Market Size by Country (2018-2023)
7.4 Europe Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Acquired Immunodeficiency Syndrome Market Size (2018-2029)
8.2 Asia-Pacific Acquired Immunodeficiency Syndrome Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Acquired Immunodeficiency Syndrome Market Size by Region (2018-2023)
8.4 Asia-Pacific Acquired Immunodeficiency Syndrome Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Acquired Immunodeficiency Syndrome Market Size (2018-2029)
9.2 Latin America Acquired Immunodeficiency Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Acquired Immunodeficiency Syndrome Market Size by Country (2018-2023)
9.4 Latin America Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size (2018-2029)
10.2 Middle East & Africa Acquired Immunodeficiency Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2018-2023)
10.4 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Acquired Immunodeficiency Syndrome Introduction
11.1.4 Takeda Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.1.5 Takeda Recent Development
11.2 AstraZeneca Eli Lilly and Company
11.2.1 AstraZeneca Eli Lilly and Company Company Detail
11.2.2 AstraZeneca Eli Lilly and Company Business Overview
11.2.3 AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Introduction
11.2.4 AstraZeneca Eli Lilly and Company Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.2.5 AstraZeneca Eli Lilly and Company Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Acquired Immunodeficiency Syndrome Introduction
11.3.4 Merck KGaA Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.3.5 Merck KGaA Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Acquired Immunodeficiency Syndrome Introduction
11.4.4 Sanofi Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.4.5 Sanofi Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Acquired Immunodeficiency Syndrome Introduction
11.5.4 Pfizer Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Acquired Immunodeficiency Syndrome Introduction
11.6.4 Amgen Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.6.5 Amgen Recent Development
11.7 Biogen
11.7.1 Biogen Company Detail
11.7.2 Biogen Business Overview
11.7.3 Biogen Acquired Immunodeficiency Syndrome Introduction
11.7.4 Biogen Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.7.5 Biogen Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Acquired Immunodeficiency Syndrome Introduction
11.8.4 Novartis Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.8.5 Novartis Recent Development
11.9 Actelion
11.9.1 Actelion Company Detail
11.9.2 Actelion Business Overview
11.9.3 Actelion Acquired Immunodeficiency Syndrome Introduction
11.9.4 Actelion Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.9.5 Actelion Recent Development
11.10 Daiichi Sankyo Company
11.10.1 Daiichi Sankyo Company Company Detail
11.10.2 Daiichi Sankyo Company Business Overview
11.10.3 Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Introduction
11.10.4 Daiichi Sankyo Company Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.10.5 Daiichi Sankyo Company Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acquired Immunodeficiency Syndrome Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
1.2.3 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.3 Market by Application
1.3.1 Global Acquired Immunodeficiency Syndrome Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Acquired Immunodeficiency Syndrome Market Perspective (2018-2029)
2.2 Acquired Immunodeficiency Syndrome Growth Trends by Region
2.2.1 Global Acquired Immunodeficiency Syndrome Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Acquired Immunodeficiency Syndrome Historic Market Size by Region (2018-2023)
2.2.3 Acquired Immunodeficiency Syndrome Forecasted Market Size by Region (2024-2029)
2.3 Acquired Immunodeficiency Syndrome Market Dynamics
2.3.1 Acquired Immunodeficiency Syndrome Industry Trends
2.3.2 Acquired Immunodeficiency Syndrome Market Drivers
2.3.3 Acquired Immunodeficiency Syndrome Market Challenges
2.3.4 Acquired Immunodeficiency Syndrome Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Acquired Immunodeficiency Syndrome Players by Revenue
3.1.1 Global Top Acquired Immunodeficiency Syndrome Players by Revenue (2018-2023)
3.1.2 Global Acquired Immunodeficiency Syndrome Revenue Market Share by Players (2018-2023)
3.2 Global Acquired Immunodeficiency Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acquired Immunodeficiency Syndrome Revenue
3.4 Global Acquired Immunodeficiency Syndrome Market Concentration Ratio
3.4.1 Global Acquired Immunodeficiency Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acquired Immunodeficiency Syndrome Revenue in 2022
3.5 Acquired Immunodeficiency Syndrome Key Players Head office and Area Served
3.6 Key Players Acquired Immunodeficiency Syndrome Product Solution and Service
3.7 Date of Enter into Acquired Immunodeficiency Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ACQUIRED IMMUNODEFICIENCY SYNDROME BREAKDOWN DATA BY TYPE
4.1 Global Acquired Immunodeficiency Syndrome Historic Market Size by Type (2018-2023)
4.2 Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Type (2024-2029)
5 ACQUIRED IMMUNODEFICIENCY SYNDROME BREAKDOWN DATA BY APPLICATION
5.1 Global Acquired Immunodeficiency Syndrome Historic Market Size by Application (2018-2023)
5.2 Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Acquired Immunodeficiency Syndrome Market Size (2018-2029)
6.2 North America Acquired Immunodeficiency Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Acquired Immunodeficiency Syndrome Market Size by Country (2018-2023)
6.4 North America Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Acquired Immunodeficiency Syndrome Market Size (2018-2029)
7.2 Europe Acquired Immunodeficiency Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Acquired Immunodeficiency Syndrome Market Size by Country (2018-2023)
7.4 Europe Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Acquired Immunodeficiency Syndrome Market Size (2018-2029)
8.2 Asia-Pacific Acquired Immunodeficiency Syndrome Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Acquired Immunodeficiency Syndrome Market Size by Region (2018-2023)
8.4 Asia-Pacific Acquired Immunodeficiency Syndrome Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Acquired Immunodeficiency Syndrome Market Size (2018-2029)
9.2 Latin America Acquired Immunodeficiency Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Acquired Immunodeficiency Syndrome Market Size by Country (2018-2023)
9.4 Latin America Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size (2018-2029)
10.2 Middle East & Africa Acquired Immunodeficiency Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2018-2023)
10.4 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Acquired Immunodeficiency Syndrome Introduction
11.1.4 Takeda Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.1.5 Takeda Recent Development
11.2 AstraZeneca Eli Lilly and Company
11.2.1 AstraZeneca Eli Lilly and Company Company Detail
11.2.2 AstraZeneca Eli Lilly and Company Business Overview
11.2.3 AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Introduction
11.2.4 AstraZeneca Eli Lilly and Company Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.2.5 AstraZeneca Eli Lilly and Company Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Acquired Immunodeficiency Syndrome Introduction
11.3.4 Merck KGaA Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.3.5 Merck KGaA Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Acquired Immunodeficiency Syndrome Introduction
11.4.4 Sanofi Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.4.5 Sanofi Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Acquired Immunodeficiency Syndrome Introduction
11.5.4 Pfizer Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Acquired Immunodeficiency Syndrome Introduction
11.6.4 Amgen Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.6.5 Amgen Recent Development
11.7 Biogen
11.7.1 Biogen Company Detail
11.7.2 Biogen Business Overview
11.7.3 Biogen Acquired Immunodeficiency Syndrome Introduction
11.7.4 Biogen Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.7.5 Biogen Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Acquired Immunodeficiency Syndrome Introduction
11.8.4 Novartis Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.8.5 Novartis Recent Development
11.9 Actelion
11.9.1 Actelion Company Detail
11.9.2 Actelion Business Overview
11.9.3 Actelion Acquired Immunodeficiency Syndrome Introduction
11.9.4 Actelion Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.9.5 Actelion Recent Development
11.10 Daiichi Sankyo Company
11.10.1 Daiichi Sankyo Company Company Detail
11.10.2 Daiichi Sankyo Company Business Overview
11.10.3 Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Introduction
11.10.4 Daiichi Sankyo Company Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023)
11.10.5 Daiichi Sankyo Company Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Acquired Immunodeficiency Syndrome Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Table 3. Key Players of Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Table 4. Global Acquired Immunodeficiency Syndrome Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Acquired Immunodeficiency Syndrome Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Acquired Immunodeficiency Syndrome Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Acquired Immunodeficiency Syndrome Market Share by Region (2018-2023)
Table 8. Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Acquired Immunodeficiency Syndrome Market Share by Region (2024-2029)
Table 10. Acquired Immunodeficiency Syndrome Market Trends
Table 11. Acquired Immunodeficiency Syndrome Market Drivers
Table 12. Acquired Immunodeficiency Syndrome Market Challenges
Table 13. Acquired Immunodeficiency Syndrome Market Restraints
Table 14. Global Acquired Immunodeficiency Syndrome Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Acquired Immunodeficiency Syndrome Market Share by Players (2018-2023)
Table 16. Global Top Acquired Immunodeficiency Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired Immunodeficiency Syndrome as of 2022)
Table 17. Ranking of Global Top Acquired Immunodeficiency Syndrome Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Acquired Immunodeficiency Syndrome Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Acquired Immunodeficiency Syndrome Product Solution and Service
Table 21. Date of Enter into Acquired Immunodeficiency Syndrome Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acquired Immunodeficiency Syndrome Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Type (2018-2023)
Table 25. Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Type (2024-2029)
Table 27. Global Acquired Immunodeficiency Syndrome Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Application (2018-2023)
Table 29. Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Application (2024-2029)
Table 31. North America Acquired Immunodeficiency Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Acquired Immunodeficiency Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Acquired Immunodeficiency Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Acquired Immunodeficiency Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Acquired Immunodeficiency Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Acquired Immunodeficiency Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029) & (US$ Million)
Table 46. Takeda Company Detail
Table 47. Takeda Business Overview
Table 48. Takeda Acquired Immunodeficiency Syndrome Product
Table 49. Takeda Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 50. Takeda Recent Development
Table 51. AstraZeneca Eli Lilly and Company Company Detail
Table 52. AstraZeneca Eli Lilly and Company Business Overview
Table 53. AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Product
Table 54. AstraZeneca Eli Lilly and Company Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 55. AstraZeneca Eli Lilly and Company Recent Development
Table 56. Merck KGaA Company Detail
Table 57. Merck KGaA Business Overview
Table 58. Merck KGaA Acquired Immunodeficiency Syndrome Product
Table 59. Merck KGaA Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 60. Merck KGaA Recent Development
Table 61. Sanofi Company Detail
Table 62. Sanofi Business Overview
Table 63. Sanofi Acquired Immunodeficiency Syndrome Product
Table 64. Sanofi Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. Pfizer Company Detail
Table 67. Pfizer Business Overview
Table 68. Pfizer Acquired Immunodeficiency Syndrome Product
Table 69. Pfizer Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Amgen Company Detail
Table 72. Amgen Business Overview
Table 73. Amgen Acquired Immunodeficiency Syndrome Product
Table 74. Amgen Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Biogen Company Detail
Table 77. Biogen Business Overview
Table 78. Biogen Acquired Immunodeficiency Syndrome Product
Table 79. Biogen Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 80. Biogen Recent Development
Table 81. Novartis Company Detail
Table 82. Novartis Business Overview
Table 83. Novartis Acquired Immunodeficiency Syndrome Product
Table 84. Novartis Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Actelion Company Detail
Table 87. Actelion Business Overview
Table 88. Actelion Acquired Immunodeficiency Syndrome Product
Table 89. Actelion Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 90. Actelion Recent Development
Table 91. Daiichi Sankyo Company Company Detail
Table 92. Daiichi Sankyo Company Business Overview
Table 93. Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Product
Table 94. Daiichi Sankyo Company Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 95. Daiichi Sankyo Company Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 1. Global Acquired Immunodeficiency Syndrome Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Table 3. Key Players of Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Table 4. Global Acquired Immunodeficiency Syndrome Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Acquired Immunodeficiency Syndrome Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Acquired Immunodeficiency Syndrome Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Acquired Immunodeficiency Syndrome Market Share by Region (2018-2023)
Table 8. Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Acquired Immunodeficiency Syndrome Market Share by Region (2024-2029)
Table 10. Acquired Immunodeficiency Syndrome Market Trends
Table 11. Acquired Immunodeficiency Syndrome Market Drivers
Table 12. Acquired Immunodeficiency Syndrome Market Challenges
Table 13. Acquired Immunodeficiency Syndrome Market Restraints
Table 14. Global Acquired Immunodeficiency Syndrome Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Acquired Immunodeficiency Syndrome Market Share by Players (2018-2023)
Table 16. Global Top Acquired Immunodeficiency Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired Immunodeficiency Syndrome as of 2022)
Table 17. Ranking of Global Top Acquired Immunodeficiency Syndrome Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Acquired Immunodeficiency Syndrome Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Acquired Immunodeficiency Syndrome Product Solution and Service
Table 21. Date of Enter into Acquired Immunodeficiency Syndrome Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acquired Immunodeficiency Syndrome Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Type (2018-2023)
Table 25. Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Type (2024-2029)
Table 27. Global Acquired Immunodeficiency Syndrome Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Application (2018-2023)
Table 29. Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Application (2024-2029)
Table 31. North America Acquired Immunodeficiency Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Acquired Immunodeficiency Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Acquired Immunodeficiency Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Acquired Immunodeficiency Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Acquired Immunodeficiency Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Acquired Immunodeficiency Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2024-2029) & (US$ Million)
Table 46. Takeda Company Detail
Table 47. Takeda Business Overview
Table 48. Takeda Acquired Immunodeficiency Syndrome Product
Table 49. Takeda Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 50. Takeda Recent Development
Table 51. AstraZeneca Eli Lilly and Company Company Detail
Table 52. AstraZeneca Eli Lilly and Company Business Overview
Table 53. AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Product
Table 54. AstraZeneca Eli Lilly and Company Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 55. AstraZeneca Eli Lilly and Company Recent Development
Table 56. Merck KGaA Company Detail
Table 57. Merck KGaA Business Overview
Table 58. Merck KGaA Acquired Immunodeficiency Syndrome Product
Table 59. Merck KGaA Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 60. Merck KGaA Recent Development
Table 61. Sanofi Company Detail
Table 62. Sanofi Business Overview
Table 63. Sanofi Acquired Immunodeficiency Syndrome Product
Table 64. Sanofi Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. Pfizer Company Detail
Table 67. Pfizer Business Overview
Table 68. Pfizer Acquired Immunodeficiency Syndrome Product
Table 69. Pfizer Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Amgen Company Detail
Table 72. Amgen Business Overview
Table 73. Amgen Acquired Immunodeficiency Syndrome Product
Table 74. Amgen Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Biogen Company Detail
Table 77. Biogen Business Overview
Table 78. Biogen Acquired Immunodeficiency Syndrome Product
Table 79. Biogen Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 80. Biogen Recent Development
Table 81. Novartis Company Detail
Table 82. Novartis Business Overview
Table 83. Novartis Acquired Immunodeficiency Syndrome Product
Table 84. Novartis Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Actelion Company Detail
Table 87. Actelion Business Overview
Table 88. Actelion Acquired Immunodeficiency Syndrome Product
Table 89. Actelion Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 90. Actelion Recent Development
Table 91. Daiichi Sankyo Company Company Detail
Table 92. Daiichi Sankyo Company Business Overview
Table 93. Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Product
Table 94. Daiichi Sankyo Company Revenue in Acquired Immunodeficiency Syndrome Business (2018-2023) & (US$ Million)
Table 95. Daiichi Sankyo Company Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Acquired Immunodeficiency Syndrome Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Acquired Immunodeficiency Syndrome Market Share by Type: 2022 VS 2029
Figure 3. Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Features
Figure 4. Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features
Figure 5. Global Acquired Immunodeficiency Syndrome Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Acquired Immunodeficiency Syndrome Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Others Case Studies
Figure 10. Acquired Immunodeficiency Syndrome Report Years Considered
Figure 11. Global Acquired Immunodeficiency Syndrome Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Acquired Immunodeficiency Syndrome Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Acquired Immunodeficiency Syndrome Market Share by Region: 2022 VS 2029
Figure 14. Global Acquired Immunodeficiency Syndrome Market Share by Players in 2022
Figure 15. Global Top Acquired Immunodeficiency Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired Immunodeficiency Syndrome as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Acquired Immunodeficiency Syndrome Revenue in 2022
Figure 17. North America Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Acquired Immunodeficiency Syndrome Market Share by Country (2018-2029)
Figure 19. United States Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Acquired Immunodeficiency Syndrome Market Share by Country (2018-2029)
Figure 23. Germany Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Acquired Immunodeficiency Syndrome Market Share by Region (2018-2029)
Figure 31. China Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Acquired Immunodeficiency Syndrome Market Share by Country (2018-2029)
Figure 39. Mexico Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Acquired Immunodeficiency Syndrome Market Share by Country (2018-2029)
Figure 43. Turkey Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Takeda Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 46. AstraZeneca Eli Lilly and Company Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 47. Merck KGaA Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 48. Sanofi Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 50. Amgen Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 51. Biogen Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 52. Novartis Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 53. Actelion Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 54. Daiichi Sankyo Company Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Figure 1. Global Acquired Immunodeficiency Syndrome Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Acquired Immunodeficiency Syndrome Market Share by Type: 2022 VS 2029
Figure 3. Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Features
Figure 4. Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features
Figure 5. Global Acquired Immunodeficiency Syndrome Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Acquired Immunodeficiency Syndrome Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Others Case Studies
Figure 10. Acquired Immunodeficiency Syndrome Report Years Considered
Figure 11. Global Acquired Immunodeficiency Syndrome Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Acquired Immunodeficiency Syndrome Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Acquired Immunodeficiency Syndrome Market Share by Region: 2022 VS 2029
Figure 14. Global Acquired Immunodeficiency Syndrome Market Share by Players in 2022
Figure 15. Global Top Acquired Immunodeficiency Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired Immunodeficiency Syndrome as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Acquired Immunodeficiency Syndrome Revenue in 2022
Figure 17. North America Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Acquired Immunodeficiency Syndrome Market Share by Country (2018-2029)
Figure 19. United States Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Acquired Immunodeficiency Syndrome Market Share by Country (2018-2029)
Figure 23. Germany Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Acquired Immunodeficiency Syndrome Market Share by Region (2018-2029)
Figure 31. China Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Acquired Immunodeficiency Syndrome Market Share by Country (2018-2029)
Figure 39. Mexico Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Acquired Immunodeficiency Syndrome Market Share by Country (2018-2029)
Figure 43. Turkey Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Acquired Immunodeficiency Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Takeda Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 46. AstraZeneca Eli Lilly and Company Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 47. Merck KGaA Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 48. Sanofi Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 50. Amgen Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 51. Biogen Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 52. Novartis Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 53. Actelion Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 54. Daiichi Sankyo Company Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
